A patient with carnitine-acylcarnitine translocase deficiency with a mild phenotype.

Abstract excerpt

Carnitine-acylcarnitine translocase deficiency, a rare beta-oxidation defect, is manifest in most cases by cardiomyopathy and death in early childhood. We report an affected patient, 3 years of age, who has had no serious complications. The residual enzyme activity in fibroblasts was higher than in previously reported patients, which may explain the benign clinical course.

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Blood Glucose
• Share to Infant, Newborn
• Share to Metabolism, Inborn Errors